Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.

CONCLUSION: H-IMRT failed to demonstrate superiority compared with C-IMRT in long-term disease outcomes. PMID: 32119599 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32119599?dopt=Abstract

Source: Clinical Prostate Cancer - March 1, 2020 Category: Cancer & Oncology Authors: Avkshtol V, Ruth KJ, Ross EA, Hallman MA, Greenberg RE, Price RA, Leachman B, Uzzo RG, Ma C, Chen D, Geynisman DM, Sobczak ML, Zhang E, Wong JK, Pollack A, Horwitz EM Tags: J Clin Oncol Source Type: research